Biologics will comprise 7 of the top 10 global medicines by spending by mid-2017. These products represent a paradigm shift in the development, manufacture, storage, testing, and delivery of medicines, with an increasing need for characterization
Biologics will comprise 7 of the top 10 global medicines by spending by mid-2017. These products represent a paradigm shift in the development, manufacture, storage, testing, and delivery of medicines, with an increasing need for characterization
